Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). (Q53669679)

17 May 2018

title

Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). (English)

1 reference

17 May 2018

1 reference

1 reference

John K Petty

1

1 reference

17 May 2018

Ken He

2

1 reference

17 May 2018

Christopher L Corless

3

1 reference

17 May 2018

John T Vetto

4

1 reference

17 May 2018

Andrew D Weinberg

5

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

17 May 2018

The American Journal of Surgery

published in

1 reference

17 May 2018

volume

183

1 reference

17 May 2018

issue

5

1 reference

17 May 2018

page(s)

512-518

1 reference

17 May 2018

T cell-based immunotherapy for cancer: a virtual reality?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

A new prognostic classification of rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cell/bacillus Calmette-Guérin vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Localization of tumor-reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

The tumor necrosis factor ligand and receptor families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

OX-40: life beyond the effector T cell stage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Characterization of activated lymphocytes in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Expression of MHC class I and class II antigens in colonic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900831-0

10.1016/S0002-9610(02)00831-0

7 January 2021

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

12034383

1 reference

17 May 2018